Insulin pill may mean end to daily shots

Jun 22, 2007

A British company has developed an insulin pill that may provide better control of diabetes symptoms than daily insulin injections.

The company Diabetology said it has found a way to enclose the insulin in a capsule that resists stomach acids and passes intact into the small intestine, where it dissolves. The insulin is then transported to the liver, where the body uses it as needed, The Times of London said Friday.

A Cardiff University team found that an oral dose taken before breakfast and before dinner controlled glucose levels successfully in 16 patients with type 2 diabetes.

The newspaper said the insulin pill more closely approximates the behavior of the pancreas, which is the source of insulin in people who don't have diabetes.

The findings were to be presented at the American Diabetes Association meeting in Chicago.

Copyright 2007 by United Press International

Explore further: Supercomputers link proteins to drug side effects

add to favorites email to friend print save as pdf

Related Stories

US company sells out of Ebola toys

7 hours ago

They might look tasteless, but satisfied customers dub them cute and adorable. Ebola-themed toys have proved such a hit that one US-based company has sold out.

UN biodiversity meet commits to double funding

8 hours ago

A UN conference on preserving the earth's dwindling resources wrapped up Friday with governments making a firm commitment to double biodiversity aid to developing countries by 2015.

Facebook unfriends federal drug agency

8 hours ago

(AP)—Facebook wants assurances from the Drug Enforcement Administration that it's not operating any more fake profile pages as part of ongoing investigations.

Partial solar eclipse over the U.S. on Thursday, Oct. 23

8 hours ago

People in most of the continental United States will be in the shadow of the Moon on Thursday afternoon, Oct. 23, as a partial solar eclipse sweeps across the Earth. For people looking through sun-safe filters, from Los Angeles, ...

Recommended for you

Supercomputers link proteins to drug side effects

20 hours ago

New medications created by pharmaceutical companies have helped millions of Americans alleviate pain and suffering from their medical conditions. However, the drug creation process often misses many side ...

No added benefit proven for umeclidinium/vilanterol in COPD

Oct 20, 2014

The drug combination umeclidinium/vilanterol (trade name Anoro) has been approved since May 2014 for adults with chronic obstructive pulmonary disease (COPD). In an early benefit assessment pursuant to the Act on the Reform ...

User comments : 0